HF 3384

as introduced - 81st Legislature (1999 - 2000) Posted on 12/15/2009 12:00am

  1.1                          A bill for an act
  1.2             relating to health; providing a grant to the board of 
  1.3             regents of the University of Minnesota for type 1 
  1.4             diabetes research; appropriating money; amending 
  1.5             Minnesota Statutes 1999 Supplement, section 144.395, 
  1.6             subdivision 2. 
  1.7   BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA: 
  1.8      Section 1.  Minnesota Statutes 1999 Supplement, section 
  1.9   144.395, subdivision 2, is amended to read: 
  1.10     Subd. 2.  [EXPENDITURES.] (a) Earnings of the fund, up to 
  1.11  five percent of the fair market value of the fund on the 
  1.12  preceding July 1, must be spent to reduce the human and economic 
  1.13  consequences of tobacco use among the youth of this state 
  1.14  through state and local tobacco prevention measures and efforts, 
  1.15  and for other public health initiatives, and for research on 
  1.16  type 1 diabetes. 
  1.17     (b) Notwithstanding paragraph (a), on January 1, 2000, up 
  1.18  to five percent of the fair market value of the fund is 
  1.19  appropriated to the commissioner of health to distribute as 
  1.20  grants under section 144.396, subdivisions 5 and 6, in 
  1.21  accordance with allocations in paragraph (c), clauses (1) and 
  1.22  (2).  Up to $200,000 of this appropriation is available to the 
  1.23  commissioner to conduct the statewide assessments described in 
  1.24  section 144.396, subdivision 3. 
  1.25     (c) Beginning July 1, 2000, and on July 1 of each year 
  1.26  thereafter, the money in paragraph (a) is appropriated as 
  2.1   follows, except as provided in paragraphs (d) and (e) to (f):  
  2.2      (1) 67 percent to the commissioner of health to distribute 
  2.3   as grants under section 144.396, subdivision 5, to fund 
  2.4   statewide tobacco use prevention initiatives aimed at youth; 
  2.5      (2) 16.5 percent to the commissioner of health to 
  2.6   distribute as grants under section 144.396, subdivision 6, to 
  2.7   fund local public health initiatives aimed at tobacco use 
  2.8   prevention in coordination with other local health-related 
  2.9   efforts to achieve measurable improvements in health among 
  2.10  youth; and 
  2.11     (3) 16.5 percent to the commissioner of health to 
  2.12  distribute in accordance with section 144.396, subdivision 7.  
  2.13     (d) A maximum of $150,000 of each annual appropriation to 
  2.14  the commissioner of health in paragraphs (b) and (c) may be used 
  2.15  by the commissioner for administrative expenses associated with 
  2.16  implementing this section. 
  2.17     (e) Beginning July 1, 2001, $1,100,000 of each annual 
  2.18  appropriation to the commissioner under paragraph (c), clause 
  2.19  (1), may be used to provide base level funding for the 
  2.20  commissioner's tobacco prevention and control programs and 
  2.21  activities.  This appropriation must occur before any other 
  2.22  appropriation under this subdivision. 
  2.23     (f) On July 1, 2000, and July 1, 2001, the commissioner 
  2.24  shall distribute $5,000,000 of each annual appropriation to the 
  2.25  commissioner under paragraph (c) as a grant to the board of 
  2.26  regents of the University of Minnesota to fund type 1 diabetes 
  2.27  research according to section 2.  The grant funds under this 
  2.28  paragraph are available to the board of regents only if the 
  2.29  funds are used to supplement and not supplant existing funding 
  2.30  from the board of regents for the diabetes institute for 
  2.31  immunology and transplantation.  This appropriation must occur 
  2.32  before any appropriation under paragraph (c).  No portion of 
  2.33  this appropriation may be used by the commissioner for 
  2.34  administrative expenses associated with implementing this 
  2.35  section. 
  2.36     Sec. 2.  [FUNDING FOR TYPE 1 DIABETES RESEARCH.] 
  3.1      Subdivision 1.  [GRANT AWARD.] The commissioner of health 
  3.2   shall distribute the funds available under Minnesota Statutes, 
  3.3   section 144.395, subdivision 2, paragraph (f), to the board of 
  3.4   regents of the University of Minnesota, to be provided to the 
  3.5   academic health center for research by the diabetes institute 
  3.6   for immunology and transplantation.  The institute shall use the 
  3.7   funds for research at the institute relating to islet cell 
  3.8   transplantation, islet cell distribution, and related areas 
  3.9   affecting persons with type 1 diabetes, including research at 
  3.10  the juvenile diabetes foundation center for islet 
  3.11  transplantation at the University of Minnesota and the juvenile 
  3.12  diabetes foundation human islet distribution program at the 
  3.13  University of Minnesota. 
  3.14     Subd. 2.  [REPORTING.] On December 1, 2001, December 1, 
  3.15  2002, and December 1, 2003, the institute shall report to the 
  3.16  commissioner and to the legislature on its use of funds received 
  3.17  under this section and progress made in research on islet cell 
  3.18  transplantation, islet cell distribution, and related areas.  In 
  3.19  reporting on its use of funds, the annual report must include, 
  3.20  but is not limited to, the amount of money the institute 
  3.21  received from the academic health center, the specific purposes 
  3.22  for which the funds were spent, and verification that the funds 
  3.23  were spent for allowable purposes according to this section.  In 
  3.24  reporting on progress made in research on transplantation, 
  3.25  distribution, and related areas, the annual report must include, 
  3.26  but is not limited to: 
  3.27     (1) data generated from the transplants on the benefits and 
  3.28  disadvantages of islet cell transplantation, including data on 
  3.29  the restoration and maintenance of tight blood sugar control and 
  3.30  insulin independence following transplantation; 
  3.31     (2) data on health care dollars per quality adjusted 
  3.32  life-year saved; and 
  3.33     (3) progress on achievement of health insurance coverage 
  3.34  for islet cell transplantation procedures. 
  3.35     Sec. 3.  [EFFECTIVE DATE.] 
  3.36     Sections 1 and 2 are effective July 1, 2000.